0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
51 Ansichten7 Seiten
Ustekinumab is now approved and widely marketed for the treatment of psoriasis. Biologic therapies target the pathogenic T cells and the inflammatory cytokines. The traditional systemic therapies, such as acitretin, methotrexate, and cyclosporine, are still used.
Originalbeschreibung:
Originaltitel
13 Psoriasis Ustekinumab and Other Biologics in the Pipeline
Ustekinumab is now approved and widely marketed for the treatment of psoriasis. Biologic therapies target the pathogenic T cells and the inflammatory cytokines. The traditional systemic ther…